Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $57.64B | $53.66B | $54.04B | $55.55B | $63.49B | $44.61B | $43.16B | $40.52B | $40.03B | $33.78B | $34.83B |
| Research & development | $524.0M | $398.0M | $245.0M | $76.0M | $65.0M | $45.0M | $45.0M | $45.0M | $58.0M | $60.0M | $104.0M |
| Operating expenses | $41.78B | $37.74B | $37.05B | $34.77B | $32.69B | $26.25B | $27.31B | $27.11B | $26.98B | $26.80B | $27.92B |
| Operating income | $14.94B | $15.65B | $14.82B | $19.93B | $29.82B | $16.83B | $11.47B | $17.69B | $14.13B | $6.79B | $3.62B |
| EBITDAderived | $21.51B | $21.57B | $20.16B | $24.94B | $34.51B | $21.11B | $15.85B | $21.70B | $18.51B | $11.59B | $8.26B |
| Net income | $9.97B | $11.55B | $10.06B | $12.39B | $21.11B | $9.77B | $8.01B | $13.64B | $8.76B | $4.62B | −$866.0M |
| Basic EPSper diluted share | $6.14 | $7.12 | $6.20 | $7.65 | $13.05 | $6.04 | $4.91 | $7.93 | $490.39 | $256.90 | -$47.50 |
| Diluted EPSper diluted share | $6.08 | $7.07 | $6.17 | $7.60 | $12.96 | $6.00 | $4.88 | $7.88 | $486.92 | $255.30 | -$47.50 |